Editorial ArticleClinical Diagnostics
How CLSI makes antimicrobial susceptibility testing possible
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
